Analysts have recently evaluated Harmonic and provided 12-month price targets. The average target is $17.5, accompanied by a ...
The approval to proceed with the Phase 2 clinical trials in Japan and Taiwan are expected to accelerate the collection of patient and response data needed for the next-stage of evaluation and ...
Harmonic (NASDAQ: HLIT) today announced that Patrick Harshman will retire as President and Chief Executive Officer, effective ...
A tremolo pedal even John Ford would have been proud to have on his 'board. Inspired by Monument Valley, it has six waveforms ...
Harmonic Divergence is a limited-edition Record Store Day special, meaning it cannot be pre-ordered and it’s only available ...
Harmonic (NASDAQ: HLIT) today announced a groundbreaking advancement in live sports streaming monetization with the ...
Though "coupled oscillations" may not sound familiar, they are everywhere in nature. The term "coupled harmonic oscillators" ...
Harmonic Drive VP Brian Coyne will explain how a low-profile, power-dense actuator can maximize power density.
Third Harmonic Bio, Inc., a biopharmaceutical company, focuses on the development of the medicine for the treatment of allergic and inflammatory diseases. It develops inflammatory diseases ...
Harmonic has announced an advancement in live sports streaming monetisation with the introduction of in-stream advertising ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback